N/A N=700 Ulipristal Emergency Contraception Used Before or After Ovulation
Contraception
Primary: Percentage of Pregnancies Prevented (PPP) — 77.5; 36.9 percentage of pregnancies prevented — p=<0.0001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=168 Initiating Contraception After Emergency Contraception From Pharmacy
Contraceptive Use After Emergency Contraception
Primary: Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) — 5; 13; 22; 0 participants — p=<0.001
N/A N=293 Same Day Oral EC and Implant Initiation
Contraception
Primary: Pregnancy Rate at One-month — 1.96 percentage of participants
N/A N=57 Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
Pregnancy
Primary: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception — 9; 13 participants
Phase 3 N=343 Emergency Contraception Actual Use Study
Emergency Contraception
Primary: Percentage of Participants Who Appropriately Self-selected DR-104 (Plan B® 1.5) When Dispensed Under Simulated Over-the-counter (OTC) Conditions — 90.1 percentage of…
N/A N=246 Contraceptive Counseling Following an Abortion
Post Abortion Care
Primary: Contraceptive Acceptability and Use of Contraceptives During the 6-month Follow-up — 121; 86 participants
Phase 4 N=36 Impact of Combined Hormonal Contraceptives on UPA
Contraception
Primary: Number of Participants With Follicle Rupture — 1; 9 Participants
N/A N=274 Levonorgestrel Intrauterine System For Emergency Contraception
Pregnancy, Unplanned · Pregnancy; Accident
Primary: Number of Participants With Pregnancy Following Emergency Contraception — 0; 0; 0; 6 Participants
Phase 3 N=1,270 A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
Emergency Contraception
Primary: Proportion of Dosing Instances Among User Population Taken Within 120 Hours (5 Days) of Most Recent Episode of Unprotected Sex. — 704 Dosing instances 120 hrs of…
Early Phase 1 N=40 Ovarian Function With ENG Implant and UPA Use
Contraception
Primary: Number of Participants With Ovulation With Implant-alone — 7; 0 Participants
Phase 3 N=860 Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
Emergency Contraception
Primary: Percentage of Pregnancies Prevented — 94.7; 63.3 percentage of pregnancies prevented — p=<0.0001
Phase 4 N=711 RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC
Contraception
Primary: Percentage of Participants Reporting a Pregnancy — 0; 0.3 % of participants reporting pregnancy
Phase 4 N=15 Emergency Contraception and Body Weight: Pilot Study
Contraception · Body Weight
Primary: Maximum Serum Concentration Between Normal and Obese BMI Women Ingesting 1.5mg Levonorgestrel — 10.3; 5.57 ng/mL
Phase 4 N=50 Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
Post Partum
Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants
N/A N=321 A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
Contraception
Primary: Continuation Rates — 82; 78; 83 participants
Phase 3 N=1,533 Safety and Efficacy of CDB-2914 for Emergency Contraception
Emergency Contraception
Primary: Pregnancy Rate — 2.1 percentage of participants
N/A N=13 Providing Adolescent Contraception in the Emergency Room
Contraception
Primary: Length of Stay — 287 minutes
Phase 3 N=2,221 Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
Contraception
Primary: Number of Participants With Pregnancy — 20; 30 Participants
N/A N=148 Nexplanon Application Post-Abortion (NAPA)
Contraception · Abortion, Therapeutic
Primary: Intention-to-treat Analysis of Etonogestrel Implant Use — 40; 19; 3; 3 Participants
N/A N=207 RCT: Can a Single Counseling Phone Call Improve Contraception After an Abortion?
Contraception
Primary: Number of Participants Using an Effective Contraceptive Method 6 Weeks After Abortion — 55; 55 Participants
Phase 4 N=88 'Levonorgestrel IUD Insertion After D&E Procedure
Contraceptive Usage
Primary: The Primary Outcome is LNG-IUD Usage Six Months Following Enrollment. — 85.2; 62.9 percentage of participants — p=0.05
Phase 4 N=70 Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG
Obesity
Primary: The Number of Participants in Two Treatment Groups (1.5mg Levonorgestrel and 3mg Levonorgestrel) With no Follicle Rupture at 5 Days Within One Menstrual (Treatment)…
N/A N=1,919 Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557)
Contraception
Primary: Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling — 1207; 1199; 60; 131 Participants — p=0.705
Phase 3 N=72 Pericoital Oral Contraception With Levonorgestrel
Healthy
Primary: Efficacy: the Pearl Index (Number of Pregnancies Per 100 Woman-years) in the Primary Evaluable Population (18-35) — 22.4 pregnancies per 100 woman years
Phase 4 N=64 Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
Obesity · Contraception
Primary: Number of Participants With Delay in Follicular Rupture Beyond 5 Days — 46; 43; 12 Participants
N/A N=298 Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion
Abortion
Primary: Number of Participants Who Use Patch After Abortion, by Study Arm — 36; 42 Participants
Phase 4 N=600 Premature Discontinuation of Contraceptive Implants
Contraception Behavior
Primary: Number of Participants With Implant Continuation — 219; 225 Participants
Phase 4 N=156 Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion
Contraception
Primary: Use of the IUD for Contraception at Six Months — 49; 51 participants — p=0.24
N/A N=138 Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
Contraceptive Usage · Opioid Dependence
Primary: Percentage of Participants With Verified Prescription Contraceptive Use at the 6-month Assessment — 5; 14; 23 Participants — p=<.001
Phase 4 N=59 Immediate vs. Delayed Postpartum Etonogestrel Implant
Continuation Rate of Contraceptive Implant
Primary: Continuation Rate — 20; 18 participants